Insituvue To Present X-Ray Technology At OneMedForum NY 2011
Insituvue is preparing to commercialize the Sonic Flashlight technology, a device developed at University of Pittsburgh that gives medical professionals a better view during procedures.
news1
NeoStem’s Suzhou Erye Receives 2 Pharma Industry Awards, Positioned For Future Growth
NeoStem announced Tuesday that Chinese generic pharma company Suzhou Erye, in which it owns a 51% majority stake, has won two awards at the 2011 Chempharm Brand Summit.
Del Mar Pharmaceuticals Is Fighting Cancer One Molecule At A Time
Del Mar Pharmaceuticals was recently added to the roster of presenting companies at OneMedForum NY 2011.
MEDomics to Present At OneMedForum NY 2011
OneMedForum NY 2011 welcomes MEDomics, LLC, a molecular diagnostic laboratory, confirmed to present in June at the annual conference.
Aduro Biotech, OneMedForum SF Presenting Company, Announces $20 Million Financing
Aduro BioTech, a OneMedForum presenting company is engineering Listeria to treat Pancreatic Cancer and other infectious diseases.
New Software From iCAD Helps Doctors Diagnose Prostate Cancer
New software being used at Englewood Hospital and Medical Center should help detect prostate cancer earlier, eliminate unnecessary testing procedures and help form a treatment plan.
OneMedForum NY 2011 Grows Its Advisory Board And Selects Initial Presenters
OneMedForum NY 2011, to be held June 23 -24, has added new members to the Advisory Board and selected an initial group of “discovery” lesser known companies with terrific growth potential.
ThermoGenesis to Begin Sale of Novel Stem Cell Device in India
ThermoGenesis said its device, used in processing stem cells from bone marrow, got Indian marketing approval, sending its shares up as much as 8 percent.
Taris Biomedical Closes $18.3 Million Financing
Taris Biomedical completes an $18.3 million B round that the company says will support the clinical development of its bladder disorder treatment drug-device combination.
Medical Device Hearings Slated For This Week On Capital Hill
A pair of hearings on Capitol Hill this week aim to peer closely at how the medical device industry interacts with regulators at the FDA.